Beam Therapeutics (BEAM): next trial readout expected around 2027-12-30
$BEAM · Beam Therapeutics Inc.Trials that could report in the next 12 months: 1BiopharmaCTG
Catalyst timeline
Dates are estimated from each trial's registered completion date — none are FDA decision dates. Counts trials that fit our shared poll budget, not everything BEAM is running — see methodology.
- 2027-12-30in 71wA Phase 1/2, Dose-Exploration Study to Evaluate the Safety and Efficacy of BEAM-301 in Patients With Glycogen Storage Disease Type Ia (GSDIa)
Pipeline
| Program | Phase | Status | Primary completion | Trial |
|---|---|---|---|---|
| A Phase 1/2, Dose-Exploration Study to Evaluate the Safety and Efficac… | Phase 1 | Recruitingstill enrolling patients | 2027-12-30 | NCT06735755 |
| A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Ref… | Phase 1 | Active Not Recruitingenrolled, still running | NCT05885464 | |
| BEACON: A Study Evaluating the Safety and Efficacy of BEAM-101 in Pati… | Phase 1 | Active Not Recruitingenrolled, still running | NCT05456880 | |
| A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patie… | Phase 1 | Recruitingstill enrolling patients | NCT06389877 |
Status-change history
Every ClinicalTrials.gov change recorded for BEAM's trials — a running history no other tracker shows.
No status changes detected yet for this ticker.
Frequently asked
When is BEAM's next PDUFA date?
No disclosed PDUFA date is currently tracked for this ticker.
What phase is BEAM's lead program in?
Phase 1 — active not recruiting.
Where does this data come from?
ClinicalTrials.gov v2 API (trial status + diffs) and company 8-K/press-release disclosures (PDUFA dates). Every number links to its source.